-+ 0.00%
-+ 0.00%
-+ 0.00%

Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update

Barchart·08/17/2026 07:14:00
Listen to the news

Appointed Pharma Industry Veteran Brendan O’Grady as Chief Executive Officer

Company on Track to Advance Clinical Programs to Key Second Half 2026 Milestones

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.